NCT00762983
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +16 more
- Locations
-
Not specified
Clinical trial condition
Rhinitis, Allergic, Perennial
Explore clinical trials studying Rhinitis, Allergic, Perennial. Study availability and eligibility vary by location and protocol.
162 public trials
4 recruiting studies
Rhinitis, Allergic, Perennial trial results
NCT00590772
- Conditions
- Fatigue, Hypersensitivity, Hypersensitivity, Immediate, +14 more
- Locations
-
Not specified
Completed
Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
NCT02238223
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified
NCT02238236
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified
NCT01270958
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
- GSK Investigational Site Hà Nội, Vietnam
NCT01270256
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
NCT01654536
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +8 more
- Locations
-
- Allergy & Asthma Associates of Southern California Mission Viejo, California, United States
- CHOC PSF AMC - Division of Allergy, Asthma and Immunology Orange, California, United States
- Allergy Associates Medical Group Inc. San Diego, California, United States
- Bensch Research Associates Stockton, California, United States
NCT02182518
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified
NCT02182544
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
- Locations
-
Not specified
Completed
Regulatory AVAMYS Nasal Spray PMS
NCT01001130
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +11 more
- Locations
-
- GSK Investigational Site Seongnam-si Gyeonggi-do, South Korea